Tango Therapeutics Inc (TNGX)
7.55
-0.24
(-3.08%)
USD |
NASDAQ |
May 17, 16:00
7.55
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Revenue (Quarterly): 6.471M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.471M |
| December 31, 2023 | 5.431M |
| September 30, 2023 | 10.73M |
| June 30, 2023 | 14.60M |
| March 31, 2023 | 5.766M |
| December 31, 2022 | 6.411M |
| September 30, 2022 | 6.92M |
| June 30, 2022 | 5.771M |
| Date | Value |
|---|---|
| March 31, 2022 | 5.758M |
| December 31, 2021 | 5.716M |
| September 30, 2021 | 6.787M |
| June 30, 2021 | 18.15M |
| March 31, 2021 | 6.386M |
| December 31, 2020 | 9.142M |
| September 30, 2020 | -11.26M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-11.26M
Minimum
Sep 2020
18.15M
Maximum
Jun 2021
6.852M
Average
6.411M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 12.05M |
| 2seventy bio Inc | 12.44M |
| NovaBay Pharmaceuticals Inc | 2.631M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.91M |
| Total Expenses (Quarterly) | 48.73M |
| EPS Diluted (Quarterly) | -0.35 |
| Enterprise Value | 459.89M |
| Profit Margin (Quarterly) | -585.9% |
| Earnings Yield | -14.76% |
| Normalized Earnings Yield | -14.76 |